Why is the demand for polymerase chain reaction (PCR) monkeypox testing rising?

The polymerase chain reaction (PCR) segment of the monkeypox testing market is forecasted to reach USD 1.3 billion by 2032 due to its high accuracy, rapid results, established technology, and crucial role in epidemiological studies and outbreak management.

Who are the leading monkeypox testing industry players?

Abbott Laboratories, Aegis Sciences Corporation, Applied DNA Sciences, Inc., Becton, Dickinson and Company, BioGX, bioM

What is the size of the monkeypox testing market?

The global monkeypox testing industry size was valued at USD 1.7 billion in 2023 and is estimated to grow at 4.5% CAGR from 2024 to 2032 due to rapid diagnostic advancements, and growing government support.

Why is the use of laboratory monkeypox testing increasing?

The laboratory testing segment of the market accounted for USD 1.1 billion in 2023 due to its ability to provide precise detection of the monkeypox virus for ensuring high sensitivity and specificity.

Monkeypox Testing Market Share

Report ID: GMI9634

Published Date: May 2024

Report Format: PDF

Download Free PDF

Monkeypox Testing Market Share

The monkeypox testing industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive storage and analysis with improved efficiency and affordability. This includes advancements in processing, precision, automation, and customization. Competition is driven by factors such as the quality, reliability, and ease of usage along with integration capabilities with existing technologies, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Monkeypox Testing Market Companies

Some of the eminent market participants operating in the monkeypox testing industry include:

Abbott Laboratories
Aegis Sciences Corporation
Applied DNA Sciences, Inc.
Becton, Dickinson and Company
BioGX
bioMérieux SA
Bio-Rad Laboratories, Inc.
CerTest Biotec
Creative Biogene
Danaher Corporation
Flow Health
Laboratory Corporation of America Holdings
Mayo Clinic Laboratories
Quest Diagnostics, Inc.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Question(FAQ) :

Why is the demand for polymerase chain reaction (PCR) monkeypox testing rising?: The polymerase chain reaction (PCR) segment of the monkeypox testing market is forecasted to reach USD 1.3 billion by 2032 due to its high accuracy, rapid results, established technology, and crucial role in epidemiological studies and outbreak management.
Who are the leading monkeypox testing industry players?: Abbott Laboratories, Aegis Sciences Corporation, Applied DNA Sciences, Inc., Becton, Dickinson and Company, BioGX, bioM
What is the size of the monkeypox testing market?: The global monkeypox testing industry size was valued at USD 1.7 billion in 2023 and is estimated to grow at 4.5% CAGR from 2024 to 2032 due to rapid diagnostic advancements, and growing government support.
Why is the use of laboratory monkeypox testing increasing?: The laboratory testing segment of the market accounted for USD 1.1 billion in 2023 due to its ability to provide precise detection of the monkeypox virus for ensuring high sensitivity and specificity.

Related Reports

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Buy now

Premium Report Details

Base Year: 2023

Companies covered: 15

Tables & Figures: 215

Countries covered: 22

Pages: 125

Download Free PDF

Monkeypox Testing Market Share

Monkeypox Testing Market Share

Monkeypox Testing Market Companies

Premium Report Details

Industries

Information

Link

Global Headquarters